Spruce Biosciences, Inc. · NASDAQ:SPRB

Ikarian Capital, LLC reported a 21.60% stake in Spruce Biosciences, Inc. (Schedule 13G)

Event Oct 6, 2025 · Filed Oct 8, 2025

Ikarian Capital, LLC reported a 21.60% stake in Spruce Biosciences, Inc., 121,356 shares, as a passive investor on Oct 6, 2025. Filed Oct 8, 2025 (Schedule 13G).

Stake
21.60%
Shares
121,356
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Ikarian Capital, LLC21.60%121,356
Neil Shahrestani21.60%121,356

Source

View original at SEC

Related